Chengdu Olymvax Biopharmaceuticals Inc. (SHA:688319)
28.54
-0.74 (-2.53%)
At close: Mar 6, 2026
100.28% (1Y)
| Market Cap | 11.58B +151.5% |
| Revenue (ttm) | 704.16M +33.7% |
| Net Income | 22.23M |
| EPS | 0.05 |
| Shares Out | 405.71M |
| PE Ratio | 520.83 |
| Forward PE | 196.83 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 7,817,871 |
| Average Volume | 5,798,375 |
| Open | 29.68 |
| Previous Close | 29.28 |
| Day's Range | 28.45 - 29.68 |
| 52-Week Range | 12.45 - 34.68 |
| Beta | 0.51 |
| RSI | 61.03 |
| Earnings Date | Mar 20, 2026 |